Delivery Order SPE2DB22D2007-SPE2DB25FJ4BD
- Not listed
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $628.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561858342 AZASITE 1% EYE DROPS 2.5ML. Performance will take place in Conshohocken, Pennsylvania over a period of three days from August 18th through the 21st of 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,658.04 firm fixed price contract is for the supply of AZASITE 1% eye drops, a specialty pharmaceutical product. The contract has an ultimate completion date of April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,102.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of AZASITE 1% eye drops. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,258.19 firm-fixed-price delivery order is for the supply of AZASITE 1% eye drops in 2.5 ml containers. The award has an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as a prime contractor without any set-aside designation. The contract is part of the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of the pharmaceutical product AZASITE 1% eye drops in 2.5 milliliter vials. The contract is valued at $1,474.02 and has a period of performance through September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $314 delivery order to Amerisourcebergen Drug Corporation for 4561708057 AZASITE 1% eye drops. As the prime, Amerisourcebergen will supply the requested pharmaceutical products to the DLA under a firm fixed price contract executed from August 4-7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facilities in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated....
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of AZASITE 1% eye drops. The contract is a Delivery Order valued at $3,203.25 with a period of performance through May 14, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a $157 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031421 AZASITE 1% eye drops. The order is for 2.5mL bottles of the eye drops and will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility between September 1-5, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor that supports the Defense Logistics Agency's medical supply needs...
- This federal contract award, valued at $7,432.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of AZASITE 1% eye drops, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract....
- This federal contract award, valued at $2,573.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of AZASITE 1% eye drops, a pharmaceutical product, to support the Department of Defense's (DoD) healthcare operations. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4BDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,548.55 to AmerisourceBergen Drug Corp for Azasite 1% Eye Drops (2.5ml) on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price delivery order is not set-aside and represents a competitively awarded transaction under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion global pharmaceutical support vehicle valued through December 2026. As a prime contractor in DLA's medical supply chain, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill diverse federal medical supply needs through open competition positions it as a critical vendor within the federal pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |